BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2009
View Archived Issues
Novel mutilin derivatives with antibacterial activity reported in recent Kyorin patent
Read More
Mpex Pharmaceuticals patent discloses novel bacterial efflux pump inhibitors
Read More
New angiotensin II AT1 receptor antagonists developed by Eldrug researchers
Read More
GSK and Archemix form strategic alliance to develop aptamers for inflammatory diseases
Read More
VIA licenses drug candidates from Roche for metabolic disease
Read More
GenVec reports on developments in malaria vaccine program
Read More
Clinical data on pralatrexate in lymphomas presented at ASH annual meeting
Read More
Phase II studies assess single-agent dasatinib in breast cancer
Read More
FDA advises NMRC not to initiate clinical trial of Biopure's Hemopure
Read More
IGF-1 does not affect outcome measures in phase III amyotrophic lateral sclerosis trial
Read More
Vinflunine with trastuzumab active as first-line treatment in metastatic breast cancer
Read More
Acura and King Pharmaceuticals submit NDA to FDA for Acurox anti-abuse opioid analgesic
Read More
EMEA accepts Schering's corifollitropin alfa submission for review
Read More
FDA's Cardio Renal Advisory Committee to review prasugrel
Read More
King provides update on Embeda NDA review
Read More
Pfizer exercises commercial license agreement for novel vaccines with Cytos
Read More
FDA approves once-daily Ryzolt for moderate to moderately severe pain
Read More
Galapagos selects preclinical candidate, G-100192, for cachexia program
Read More
Alnylam files IND application with FDA to initiate phase I human clinical trial of ALN-VSP
Read More
Roche purchases shares in tender offer for Memory Pharmaceuticals
Read More
Death of Chinese minor not related to Sinovac's hepatitis A vaccine Healive
Read More
Valeant Pharmaceuticals International completes acquisition of Dow Pharmaceutical Sciences
Read More
Lodotra recommended for European regulatory approval
Read More
MedImmune submits MAA in European Union for intranasal influenza
Read More